Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non-small cell lung cancer.
Allen Chung-Cheng HuangChin-Chou WangYu-Chen HuangStelios PavlidisChien-Ying LiuHow-Wen KoFu-Tsai ChungTin-Yu LinChih-Liang WangYi-Ke GuoCheng-Ta YangPublished in: Thoracic cancer (2019)
Combing chemotherapy with ICIs improved treatment efficacy over ICIs alone. The additional efficacy of chemotherapy may differ between histological subtypes and EGFR mutation status.